H2AI34 Stock Overview
Manufactures, markets, and sells organic and natural products in United States, United Kingdom, Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
The Hain Celestial Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$40.65 |
52 Week High | US$40.65 |
52 Week Low | US$40.65 |
Beta | 0.76 |
11 Month Change | 0% |
3 Month Change | -1.26% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 1.32% |
Recent News & Updates
Recent updates
Shareholder Returns
H2AI34 | BR Food | BR Market | |
---|---|---|---|
7D | 0% | 3.4% | -1.4% |
1Y | n/a | 47.8% | 3.3% |
Return vs Industry: Insufficient data to determine how H2AI34 performed against the BR Food industry.
Return vs Market: Insufficient data to determine how H2AI34 performed against the BR Market.
Price Volatility
H2AI34 volatility | |
---|---|
H2AI34 Average Weekly Movement | n/a |
Food Industry Average Movement | 4.4% |
Market Average Movement | 4.5% |
10% most volatile stocks in BR Market | 8.8% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: H2AI34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine H2AI34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 3,078 | Mark Schiller | www.hain.com |
The Hain Celestial Group, Inc. manufactures, markets, and sells organic and natural products in United States, United Kingdom, and internationally. It operates through two segments, North America and International. The company offers infant formula; infant, toddler, and kids’ food; plant-based beverages and frozen desserts, such as soy, rice, oat, almond, and coconut; and condiments.
The Hain Celestial Group, Inc. Fundamentals Summary
H2AI34 fundamental statistics | |
---|---|
Market cap | R$7.37b |
Earnings (TTM) | R$404.60m |
Revenue (TTM) | R$9.83b |
18.2x
P/E Ratio0.7x
P/S RatioIs H2AI34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
H2AI34 income statement (TTM) | |
---|---|
Revenue | US$1.89b |
Cost of Revenue | US$1.46b |
Gross Profit | US$427.44m |
Other Expenses | US$349.57m |
Earnings | US$77.87m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.87 |
Gross Margin | 22.59% |
Net Profit Margin | 4.12% |
Debt/Equity Ratio | 82.0% |
How did H2AI34 perform over the long term?
See historical performance and comparison